Ligand Pharmaceuticals | LGND - Loan Capital

Stock Price
190.44
Daily Change
-1.25 -0.65%
Monthly
-4.76%
Yearly
65.33%
Q1 Forecast
186.18

Ligand Pharmaceuticals reported $445.49M in Loan Capital for its fiscal quarter ending in September of 2025.





Loan Capital Change Date
Amgen USD 52.43B 1.33B Sep/2025
Arrowhead Research USD 538.1M 323.22M Dec/2025
Baxter International USD 9.49B 80M Jun/2025
Bristol-Myers Squibb USD 42.85B 1.62B Dec/2025
Eli Lilly USD 40.87B 6.69B Sep/2025
Gilead Sciences USD 22.14B 5M Sep/2025
GlaxoSmithKline GBP 14.71B 186M Dec/2025
Glaxosmithkline GBP 20.02B 4.72B Sep/2025
Insmed USD 539.72M 21.23M Sep/2025
Ionis Pharmaceuticals USD 28.78M 596.71M Sep/2025
Ligand Pharmaceuticals USD 445.49M 445.44M Sep/2025
MacroGenics USD 70.26M 4K Sep/2025
Merck USD 39.97B 6B Sep/2025
Pacira USD 376.72M 1.37M Sep/2025
Pfizer USD 57.41B 93M Sep/2025
Veracyte USD 0 0 Mar/2025